Dayli Partners ^Investor

Dayli Partners is an investment firm located in Seoul, Seoul-t'ukpyolsi, South Korea. Founded on January 1, 2018, the firm operates primarily in the Asia-Pacific (APAC) region. With a focus on biotech, pharma, and Biomed sectors, Dayli Partners has made notable investments in companies such as Genoplan, Galux, PharmCADD, and Medipixel. These investments highlight the firm's commitment to supporting innovative and cutting-edge advancements in healthcare and technology within the APAC region.